Financials

  • Market Capitalization 2.33 B
  • Employee 305
  • Founded 2018
  • CEO David Hung
  • Website www.nuvationbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VHJ0CC1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-12.91
市销率
0.01

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
1872
TRVI
Trevi Therapeutics, Inc. - Common Stock
16.57 USD-0.18%-7.38%-9.60%+131.10%2.36 B USD
1883
KOD
Kodiak Sciences Inc - Common Stock
37.06 USD-0.78%-7.21%-10.87%+333.96%2.33 B USD
1886
OCUL
Ocular Therapeutix, Inc. - Common Stock
10.57 USD+0.76%-2.04%+26.59%-8.09%2.32 B USD
1900
PHVS
Pharvaris N.V. - Ordinary Shares
34.93 USD+0.92%-6.38%+7.71%+55.18%2.28 B USD

新闻